GWLL

Goldenwell Biotech, Inc. Stock Price

OTCPK:GWLL Community·US$277.2m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

GWLL Share Price Performance

US$2.80
2.60 (1,300.00%)
US$2.80
2.60 (1,300.00%)
Price US$2.80

GWLL Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Moderate risk with worrying balance sheet.

5 Risks
0 Rewards

Goldenwell Biotech, Inc. Key Details

US$62.3k

Revenue

-US$73.0

Cost of Revenue

US$62.4k

Gross Profit

US$137.5k

Other Expenses

-US$75.1k

Earnings

Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
n/a
-0.00076
100.12%
-120.49%
-290.9%
View Full Analysis

About GWLL

Founded
2019
Employees
n/a
CEO
Shuang Liu
Website
n/a

Goldenwell Biotech, Inc., focuses on nutraceutical and dietary supplements business in the United States. It is developing JI MAI, a bovine cardiac vascular active peptide; Double Proline AG, a 3D active collagen peptide drinkable cosmetic; Cartilage Peptide, a Type II collagen peptide; and Sugar Master, a dietary supplement. The company was incorporated in 2019 and is based in Hudson, Ohio.

Recent GWLL News & Updates

Recent updates

No updates